Bicocca Open Archive

Logo unimib boa
FONTANA, DILETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.057
EU - Europa 2.272
AS - Asia 908
SA - Sud America 23
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 6.276
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.009
IT - Italia 842
DE - Germania 475
SG - Singapore 369
IE - Irlanda 271
CN - Cina 229
SE - Svezia 206
RU - Federazione Russa 155
HK - Hong Kong 98
GB - Regno Unito 87
ID - Indonesia 68
FR - Francia 49
FI - Finlandia 48
UA - Ucraina 43
CA - Canada 38
VN - Vietnam 35
IN - India 31
TR - Turchia 25
IQ - Iraq 23
DK - Danimarca 21
BE - Belgio 16
CZ - Repubblica Ceca 15
IR - Iran 10
JP - Giappone 10
MX - Messico 10
AT - Austria 9
PE - Perù 9
NL - Olanda 8
EC - Ecuador 6
ES - Italia 6
EU - Europa 5
KR - Corea 5
LT - Lituania 5
NZ - Nuova Zelanda 5
PL - Polonia 5
BR - Brasile 4
EG - Egitto 4
NO - Norvegia 3
RO - Romania 3
AM - Armenia 2
AR - Argentina 2
BG - Bulgaria 2
CO - Colombia 2
PK - Pakistan 2
CH - Svizzera 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
PT - Portogallo 1
SC - Seychelles 1
Totale 6.276
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.055
Frankfurt am Main 375
Singapore 304
Milan 299
Dublin 268
Chandler 224
Wilmington 171
Fairfield 167
Ashburn 124
Houston 118
New York 99
Hong Kong 94
Santa Clara 94
Dearborn 91
Woodbridge 84
Jakarta 65
Seattle 62
Princeton 56
Shanghai 53
Cambridge 45
Jacksonville 39
Beijing 37
Helsinki 32
Boyds 31
Altamura 30
Munich 29
Nanjing 29
Lawrence 26
Kirkuk 23
Dong Ket 21
Guangzhou 19
Los Angeles 19
Romola 18
Boardman 17
Monza 16
Brussels 15
Kocaeli 15
Pavia 15
Carate Brianza 14
San Diego 14
Genoa 13
Lissone 12
Toronto 12
Fremont 11
Meda 11
Ottawa 11
Andover 10
London 10
Rome 10
Sesto San Giovanni 10
Cesano Maderno 9
Como 9
Nanchang 9
Pune 9
Turin 9
Vienna 9
Brno 8
Falls Church 8
Shenyang 8
Chicago 7
Cinisello Balsamo 7
Desio 7
Lappeenranta 7
Lodi 7
Riva del Garda 7
Tianjin 7
Assago 6
Bari 6
Bologna 6
Edmonton 6
Göttingen 6
Hebei 6
Jinan 6
Kunming 6
Lima 6
Marseille 6
Trento 6
Washington 6
Auckland 5
Brescia 5
Cuenca 5
Hanoi 5
Lachine 5
Motta Di Livenza 5
Taku 5
Treviso 5
Bergamo 4
Cagliari 4
Cesena 4
Dallas 4
Giza 4
Grafing 4
Hangzhou 4
Hounslow 4
Knoxville 4
Lodz 4
Meaux 4
Nova Milanese 4
Olomouc 4
Paris 4
Totale 4.712
Salva come PNG Salva come JPEG
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 406
Characterization of the role of mutated ETNK1 in the onset of atypical Chronic Myeloid Leukemia 324
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 304
Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: clinical and biological correlates 291
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 273
ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity 259
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 256
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 239
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 205
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 204
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma 197
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients 195
Large-Scale Analysis of SARS-CoV-2 Synonymous Mutations Reveals the Adaptation to the Human Codon Usage During the Virus Evolution 190
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 189
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 189
Erratum: Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design (Journal of Medicinal Chemistry (2017) 60:22 (9205-9221) DOI: 10.1021/acs.jmedchem.7b01039) 183
Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK 159
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 158
Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation 158
Impact of ETNK1 somatic mutations on phosphoethanolamine synthesis, ROS production and DNA damage 149
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 142
Phase ii study with crizotinib in patients with anaplastic lymphoma kinase (alk)-positive lymphoma relapsed/refractory to chemotherapy 140
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 132
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 128
Abstract 3583: Drug-resistant NPM/ALK mutants show different sensitivity to second generation tyrosine kinase inhibitors 119
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 114
Idiopathic erythrocytosis: a germline disease? 95
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution 93
Erratum: Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma (Molecular Cancer Research (2015) 13 (775-783)) 90
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 85
Mechanisms of resistance to the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma cells 84
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 80
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 76
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 67
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706) 66
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience 64
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 64
Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review 63
Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia 61
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis 60
Role of somatic ETNK1 mutation in the mitochondrial activity 53
Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer 45
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 40
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 39
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape 37
ETNK1 mutations increase mitochondrial activity and promote DNA damage through ROS production 37
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia 34
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia 26
Totale 6.662
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.755
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.755
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020496 0 0 0 0 0 79 104 45 64 117 60 27
2020/20211.295 35 42 113 116 112 114 182 128 110 108 124 111
2021/2022651 84 88 79 61 36 59 21 20 30 43 56 74
2022/20231.152 108 271 124 104 110 152 18 62 64 34 32 73
2023/20241.216 46 43 64 76 122 276 235 36 105 52 51 110
2024/20251.133 149 284 170 172 254 104 0 0 0 0 0 0
Totale 6.662